Trial Profile
A Phase I Study to Evaluate the Effect of Repeated Oral Doses of Delafloxacin on the Pharmacokinetics of a Single Oral Dose of Midazolam in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 May 2017
Price :
$35
*
At a glance
- Drugs Delafloxacin (Primary) ; Midazolam (Primary)
- Indications Community-acquired pneumonia; Intra-abdominal infections; Nosocomial pneumonia; Skin and soft tissue infections; Urinary tract infections
- Focus Pharmacokinetics
- Sponsors Melinta Therapeutics
- 08 May 2017 Results published in the Clinical Therapeutics
- 14 Jun 2016 Data will be presented at the ASM Microbe 2016, according to a Melinta Therapeutics media release.
- 01 Aug 2015 New trial record